OA
ICPT

Operose Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Operose Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$1.85K – 756
2023
Q3 		$1.85K Hold
100
– – ﹤0.01% 710
2023
Q2 		$1.11K Hold
100
– – ﹤0.01% 337
2023
Q1 		$1.34K Sell
100
-200
-67% -$3.46K ﹤0.01% 322
2022
Q4 		$3.71K Buy
+300
New +$4.25K ﹤0.01% 325

Operose Advisors's ICPT Position: Q4 2023 in Review

Operose Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 100 shares — an estimated $1.85K sold.

Operose Advisors first reported a position in ICPT in Q4 2022 and held it in 4 quarters. The position peaked at $3.71K in Q4 2022. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Operose Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Operose Advisors sold 100 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $1.85K.
  • Operose Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2022 and held it in 4 quarters.
  • Operose Advisors's Intercept Pharmaceuticals, Inc. position peaked at $3.71K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.